BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34856746)

  • 1. Synergistic antimicrobial activity of a novel cationic micelle L/D2 and imipenem against multidrug-resistant Acinetobacter baumannii.
    Zhong G; Zhang Y; Yu K; Wen L; Lu H; Zheng Y
    Front Biosci (Landmark Ed); 2021 Nov; 26(11):977-987. PubMed ID: 34856746
    [No Abstract]   [Full Text] [Related]  

  • 2. Degradable antimicrobial polycarbonates with unexpected activity and selectivity for treating multidrug-resistant Klebsiella pneumoniae lung infection in mice.
    Yang C; Lou W; Zhong G; Lee A; Leong J; Chin W; Ding B; Bao C; Tan JPK; Pu Q; Gao S; Xu L; Hsu LY; Wu M; Hedrick JL; Fan W; Yang YY
    Acta Biomater; 2019 Aug; 94():268-280. PubMed ID: 31129359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly synergistic activity of melittin with imipenem and colistin in biofilm inhibition against multidrug-resistant strong biofilm producer strains of Acinetobacter baumannii.
    Bardbari AM; Arabestani MR; Karami M; Keramat F; Aghazadeh H; Alikhani MY; Bagheri KP
    Eur J Clin Microbiol Infect Dis; 2018 Mar; 37(3):443-454. PubMed ID: 29353377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro activity of polymyxin B in combination with imipenem, rifampicin and azithromycin versus multidrug resistant strains of Acinetobacter baumannii producing OXA-23 carbapenemases.
    Wareham DW; Bean DC
    Ann Clin Microbiol Antimicrob; 2006 Apr; 5():10. PubMed ID: 16630352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imipenem: a potent inducer of multidrug resistance in Acinetobacter baumannii.
    Kuo HY; Chang KC; Kuo JW; Yueh HW; Liou ML
    Int J Antimicrob Agents; 2012 Jan; 39(1):33-8. PubMed ID: 21996406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of Colistin-Ampicillin/Sulbactam Combination Efficacy in Imipenem-Resistant Acinetobacter baumannii Strains].
    Cıkman A; Ceylan MR; Parlak M; Karahocagil MK; Berktaş M
    Mikrobiyol Bul; 2013 Jan; 47(1):147-51. PubMed ID: 23390912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial and Anti-Biofilm Peptide Octominin for Controlling Multidrug-Resistant
    Jayathilaka EHTT; Rajapaksha DC; Nikapitiya C; De Zoysa M; Whang I
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069596
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii.
    Principe L; D'Arezzo S; Capone A; Petrosillo N; Visca P
    Ann Clin Microbiol Antimicrob; 2009 May; 8():18. PubMed ID: 19460166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro synergistic effect of amlodipine and imipenem on the expression of the AdeABC efflux pump in multidrug-resistant Acinetobacter baumannii.
    Hu C; Li Y; Zhao Z; Wei S; Zhao Z; Chen H; Wu P
    PLoS One; 2018; 13(6):e0198061. PubMed ID: 29856791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Signatures from Adaptation of Bacteria to Lytic Phage Identify Potential Agents To Aid Phage Killing of Multidrug-Resistant Acinetobacter baumannii.
    Oyejobi GK; Xiong D; Shi M; Zhang X; Yang H; Xue H; Ogolla F; Wei H
    J Bacteriol; 2022 Mar; 204(3):e0059321. PubMed ID: 35156836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
    Turk Dagi H; Kus H; Arslan U; Tuncer I
    Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter baumannii, including colistin- or tigecycline-resistant isolates.
    Peck KR; Kim MJ; Choi JY; Kim HS; Kang CI; Cho YK; Park DW; Lee HJ; Lee MS; Ko KS
    J Med Microbiol; 2012 Mar; 61(Pt 3):353-360. PubMed ID: 22016557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of lytic phage T1245 with antibiotics for enhancement of antibacterial and anti-biofilm efficacy against multidrug-resistant
    Soontarach R; Nwabor OF; Voravuthikunchai SP
    Biofouling; 2022 Nov; 38(10):994-1005. PubMed ID: 36606321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan.
    Hsueh SC; Lee YJ; Huang YT; Liao CH; Tsuji M; Hsueh PR
    J Antimicrob Chemother; 2019 Feb; 74(2):380-386. PubMed ID: 30357343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of rifampicin alone and in combination with imipenem against multidrug-resistant Acinetobacter baumannii harboring the blaOXA-72 resistance gene.
    Majewski P; Wieczorek P; Ojdana D; Sacha PT; Wieczorek A; Tryniszewska EA
    Scand J Infect Dis; 2014 Apr; 46(4):260-4. PubMed ID: 24447252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Multifunctional Silver Nanocomposite Serves as a Resistance-Reversal Agent to Synergistically Combat Carbapenem-Resistant
    Li X; Gui R; Li J; Huang R; Shang Y; Zhao Q; Liu H; Jiang H; Shang X; Wu X; Nie X
    ACS Appl Mater Interfaces; 2021 Jul; 13(26):30434-30457. PubMed ID: 34161080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Clinical mNGS-Based Machine Learning Model for Rapid Antimicrobial Susceptibility Testing of Acinetobacter baumannii.
    Hu X; Zhao Y; Han P; Liu S; Liu W; Mai C; Deng Q; Ren J; Luo J; Chen F; Jia X; Zhang J; Rao G; Gu B
    J Clin Microbiol; 2023 May; 61(5):e0180522. PubMed ID: 37022167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nosocomial infection by sequence type 357 multidrug-resistant Acinetobacter baumannii isolates in a neonatal intensive care unit in Daejeon, Korea.
    Sung JY; Koo SH; Cho HH; Kwon KC
    Ann Lab Med; 2013 Jul; 33(4):279-82. PubMed ID: 23826565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial polymers as therapeutics for treatment of multidrug-resistant Klebsiella pneumoniae lung infection.
    Lou W; Venkataraman S; Zhong G; Ding B; Tan JPK; Xu L; Fan W; Yang YY
    Acta Biomater; 2018 Sep; 78():78-88. PubMed ID: 30031912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of the efflux pump inhibitor Carbonyl Cyanide m-Chlorophenylhydrazone (CCCP) on the susceptibility to imipenem and cefepime in clinical strains of Acinetobacter baumannii.
    Sanchez-Carbonel A; Mondragón B; López-Chegne N; Peña-Tuesta I; Huayan-Dávila G; Blitchtein D; Carrillo-Ng H; Silva-Caso W; Aguilar-Luis MA; Del Valle-Mendoza J
    PLoS One; 2021; 16(12):e0259915. PubMed ID: 34919563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.